Nutrien Ltd. (NYSE: NTR) closed the day trading at $72.68 down -0.41% from the previous closing price of $72.98. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 1926369 shares were traded. NTR stock price reached its highest trading level at $73.74 during the session, while it also had its lowest trading level at $71.29.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Ratios:
For a better understanding of NTR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 41.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.13. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 1.10. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.35.
Upgrades & Downgrades
On February 03, 2023, Raymond James Downgraded its rating to Mkt Perform which previously was Outperform but kept the price unchanged to $90.
On January 19, 2023, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $80.Wells Fargo initiated its Equal Weight rating on January 19, 2023, with a $80 target price.
Valuation Measures:
As of this moment, Nutrien’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.73, and their Forward P/E ratio for the next fiscal year is 8.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.00 while its Price-to-Book (P/B) ratio in mrq is 1.05.
Stock Price History:
Over the past 52 weeks, NTR has reached a high of $117.25, while it has fallen to a 52-week low of $68.82. The 50-Day Moving Average of the stock is 78.13, while the 200-Day Moving Average is calculated to be 82.01.
Shares Statistics:
Over the past 3-months, NTR traded about 2.18M shares per day on average, while over the past 10 days, NTR traded about 2.77M shares per day. A total of 516.57M shares are outstanding, with a floating share count of 499.04M. Insiders hold about 0.03% of the company’s shares, while institutions hold 72.17% stake in the company. Shares short for NTR as of Jan 30, 2023 were 6.11M with a Short Ratio of 5.84M, compared to 8.04M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.18% and a Short% of Float of 1.18%.
Dividends & Splits
NTR’s forward annual dividend rate is 2.84, up from 1.80 a year ago. Against a Trailing Annual Dividend Yield of 2.47%, it implies a Forward Annual Dividend Yield of 2.44%. The stock’s 5-year Average Dividend Yield is 3.15. The current Payout Ratio is 9.80% for NTR, which recently paid a dividend on Apr 12, 2023 with an ex-dividend date of Dec 28, 2022. Stock splits for the company last occurred on Jan 01, 2018 when the company split stock in a 0:1 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 16 analysts. On average, analysts expect EPS of $2.62 for the current quarter, with a high estimate of $2.95 and a low estimate of $2.26, while EPS last year was $2.47. The consensus estimate for the next quarter is $2.27, with high estimates of $2.77 and low estimates of $1.76.
Analysts are recommending an EPS of between $14.64 and $13.41 for the fiscal current year, implying an average EPS of $13.82. EPS for the following year is $11.49, with 20 analysts recommending between $14.21 and $8.42.
Revenue Estimates
9 analysts predict $7.44B in revenue for the current quarter. It ranges from a high estimate of $8.09B to a low estimate of $6.7B. As of the current estimate, Nutrien Ltd.’s year-ago sales were $7.07B, an estimated increase of 5.30% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $7B, a decrease of -6.10% less than the figure of $5.30% in the same quarter last year. There is a high estimate of $7.6B for the next quarter, whereas the lowest estimate is $6.42B.
A total of 15 analysts have provided revenue estimates for NTR’s current fiscal year. The highest revenue estimate was $39.32B, while the lowest revenue estimate was $36.42B, resulting in an average revenue estimate of $37.75B. In the same quarter a year ago, actual revenue was $26.86B, up 40.50% from the average estimate. Based on 15 analysts’ estimates, the company’s revenue will be $33.87B in the next fiscal year. The high estimate is $37.3B and the low estimate is $31.08B. The average revenue growth estimate for next year is down -10.30% from the average revenue estimate for this year.
